本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Castle Biosciences, Inc.

33.44
+1.113.43%
盤後33.440.00000.00%19:30 EDT
成交量:16.54萬
成交額:547.22萬
市值:10.22億
市盈率:-51.12
高:33.53
開:32.30
低:32.16
收:32.33
52周最高:44.28
52周最低:17.72
股本:3,054.95萬
流通股本:2,821.96萬
量比:0.78
換手率:0.59%
股息:- -
股息率:- -
每股收益(TTM):-0.6542
每股收益(LYR):-0.8334
淨資產收益率:-4.20%
總資產收益率:-1.36%
市淨率:2.17
市盈率(LYR):-40.12

資料載入中...

2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

重要事件披露

Form 8-K - Current report
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/05

重要事件披露

Form 8-K - Current report
2024/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities